Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22632451)

Published in J Dermatolog Treat on July 09, 2012

Authors

Atsuyuki Igarashi1, Hiroyo Kuwabara, Kyle Fahrbach, Brad Schenkel

Author Affiliations

1: Department of Dermatology, NTT Medical Center Tokyo, Tokyo, Japan. igarashi@east.ntt.co.jp

Articles by these authors

Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91

The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46

Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery (2007) 2.35

Meta-analysis of alignment outcomes in computer-assisted total knee arthroplasty surgery. J Arthroplasty (2007) 2.26

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res (2008) 2.02

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf (2010) 1.95

Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol Genet Metab (2007) 1.86

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest (2004) 1.80

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis. Kidney Int (2004) 1.68

Effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia. Oncologist (2005) 1.41

Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis. Cancer (2004) 1.17

Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci (2011) 1.16

Minimally invasive colorectal resection outcomes: short-term comparison with open procedures. J Am Coll Surg (2006) 1.10

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol (2010) 1.10

Studies of Swedish adjustable gastric band and Lap-Band: systematic review and meta-analysis. Surg Obes Relat Dis (2008) 0.98

Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation. Cardiovasc Drugs Ther (2012) 0.97

The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review. Clin Ther (2003) 0.97

An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myeloma. Leuk Lymphoma (2007) 0.93

Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives--an update. Ann N Y Acad Sci (2012) 0.91

Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives. Ann N Y Acad Sci (2011) 0.90

Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2. J Dermatolog Treat (2010) 0.86

Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. J Drugs Dermatol (2011) 0.86

The value to patients of reducing lesion severity in plaque psoriasis. J Dermatolog Treat (2011) 0.85

Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis. Curr Med Res Opin (2008) 0.85

Ultrasonic and nonultrasonic instrumentation: a systematic review and meta-analysis. Arch Surg (2008) 0.84

Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis. Future Oncol (2014) 0.84

Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis. Pediatr Crit Care Med (2011) 0.83

Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial. J Drugs Dermatol (2013) 0.83

Ustekinumab dosing, persistence, and discontinuation patterns in patients with moderate-to-severe psoriasis. J Dermatolog Treat (2014) 0.82

Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis. J Dermatolog Treat (2011) 0.82

Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial. J Dermatol (2012) 0.80

Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality. Int J Cardiol (2005) 0.79

Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: results from the PEARL trial. J Drugs Dermatol (2012) 0.78

Efficacy of selected treatments of HIV wasting: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2004) 0.78

Cost utility analysis based on a head-to-head Phase 3 trial comparing ustekinumab and etanercept in patients with moderate-to-severe plaque psoriasis: a Canadian perspective. Value Health (2011) 0.77

Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece. BMC Dermatol (2012) 0.76

Navigated total knee replacement. J Bone Joint Surg Am (2007) 0.75

Disparities associated with breast reconstruction in Japan. Plast Reconstr Surg (2013) 0.75

Regional Variation in the Use of Percutaneous Coronary Intervention in Japan. Circ J (2016) 0.75